Benson Ruth A, Poole Rebecca, Murray Shelagh, Moxey Paul, Loftus Ian M
Department of Academic Vascular Surgery, St George's Vascular Institute, St George's NHS Healthcare Trust, London, United Kingdom.
Department of Academic Vascular Surgery, St George's Vascular Institute, St George's NHS Healthcare Trust, London, United Kingdom.
J Vasc Surg. 2016 Feb;63(2):301-4. doi: 10.1016/j.jvs.2015.08.091. Epub 2015 Oct 23.
After its introduction in six pilot centers in 2009, the National Abdominal Aortic Aneurysm Screening Programme (NAAASP) is now established across the United Kingdom, demonstrating significant benefit in terms of fewer emergency surgeries and reduced 30-day surgical mortality. However, according to publication of data on annual screened abdominal aortic aneurysm (AAA) detection, a lower incidence than predicted in the original screening trials has been found. In this audit we assessed features and risk factors of men found to have a positive scan result in the southwest London AAA screening program, to determine screening yield for subgroups of populations and assess the case for a more targeted screening program.
Data from the NAAASP screening database for England were extracted for all men who attended screening from the April 1, 2009 through October 16, 2013 in the southwest London area. Primary outcomes were aneurysm prevalence, risk factors, and incidence within subgroups. Results were reviewed against nationally reported data and London census data.
Of 24,891 men who were screened in the southwest London program during this period, 292 AAAs were identified (1.18%). Patients were asked to categorize their ethnic background according to classifications provided by the office of national statistics. Those at highest risk of AAA were white-British (1.35%), followed by black and black British (0.65%), and Asian/Asian British (0.23%). Number needed to screen to identify one AAA was calculated as 78, 154, and 431, respectively. The relative proportions of patients screened were similar to that described in the most recent United Kingdom census, except for white-British patients, indicating a shortfall in acceptance of screening invitations in this group. There were no AAA identified in Chinese men. A positive smoking history was found in 90%, a confirmed diagnosis of hypertension in 50%, hypercholesterolemia in 34%, and ischemic heart disease in 21%.
Within southwest London, AAA was most strongly associated with being white-British, a previous or current smoker, and known hypertension. Targeted education in patient groups with identified risk factors for AAA should be considered to improve screening yield without excluding any subgroup from the screening program. This could draw on resources released by unused scans because of lower than predicted prevalence. AAA diagnosis should be seen as an opportunity to address the increased all-cause mortality associated with aortic aneurysmal disease.
2009年在6个试点中心推行后,英国现已全面开展国家腹主动脉瘤筛查计划(NAAASP),该计划在减少急诊手术和降低30天手术死亡率方面显示出显著益处。然而,根据年度筛查腹主动脉瘤(AAA)检测数据的公布情况,发现其发病率低于最初筛查试验中的预测值。在本次审计中,我们评估了伦敦西南部AAA筛查项目中扫描结果呈阳性的男性的特征和风险因素,以确定不同人群亚组的筛查收益,并评估实施更具针对性的筛查项目的理由。
从NAAASP筛查数据库中提取2009年4月1日至2013年10月16日期间在伦敦西南部地区参加筛查的所有男性的数据。主要结局指标为亚组内的动脉瘤患病率、风险因素和发病率。将结果与全国报告的数据和伦敦人口普查数据进行对比。
在此期间,伦敦西南部项目中接受筛查的24,891名男性中,确诊292例AAA(1.18%)。患者被要求根据国家统计局提供的分类标准对自己的种族背景进行分类。AAA风险最高的是英国白人(1.35%),其次是黑人及英国黑人(0.65%),以及亚洲/亚裔英国人(0.23%)。发现筛查出1例AAA所需的筛查人数分别为78、154和431。除英国白人患者外,接受筛查的患者相对比例与英国最新人口普查中的描述相似,这表明该组接受筛查邀请的人数不足。未在中国男性中发现AAA病例。90%的患者有吸烟史阳性,50%确诊患有高血压,34%患有高胆固醇血症,21%患有缺血性心脏病。
在伦敦西南部,AAA与英国白人、既往或当前吸烟者以及已知高血压的关联性最强。应考虑对已确定有AAA风险因素的患者群体进行针对性教育,以提高筛查收益,同时不将任何亚组排除在筛查项目之外。这可以利用因患病率低于预期而未使用的扫描所释放的资源。AAA诊断应被视为解决与主动脉瘤疾病相关的全因死亡率上升问题的契机。